Director / Editor: Victor Teboul, Ph.D.

Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

Ozempic’s cousin drug liraglutide is about to get cheaper. But how does it stack up?

By Sebastian Furness, ARC Future Fellow, School of Biomedical Sciences, The University of Queensland

Patents for a drug related to Ozempic have expired, so pharmaceutical companies are working to develop ‘generic’ versions. These are likely to be much cheaper. But how do they compare with Ozempic?

Read complete article

~	In a largely uneventful and inconsequential US vice presidential debate, no one can claim victory

~	Oil prices set to rise as Middle East tensions worsen, adding to cost-of-living crisis

~	Iran’s leaders have everything to lose in a direct war with Israel. Why take such a massive risk?

~	Cambodia: Charges against journalist highlight clampdown on press freedom

~	China/Hong Kong: Amnesty International recognizes three activists as prisoners of conscience

~	Northeast Syria: Military Recruitment of Children Persists

~	America’s dad vs. the manosphere: Walz-Vance debate highlights two versions of masculinity

~	What the facial expressions of Tim Walz and JD Vance said about their nerves, embarrassment and pride

~	Egypt: Reject Draft Criminal Procedure Code

~	Sri Lanka: UN Rights Council Should Extend Crucial Mandate